| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| closedAccess |  | 15-jun-2021 | A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia | Vives, Susana; Martínez-Cuadrón, David; Bergua, Juan; Algarra, Lorenzo; Tormo, Mar; Martínez-Sánchez, María Pilar; Serrano-López, Josefina; Herrera, Pilar; Ramos, Fernando; Salamero, Olga; Lavilla, Esperanza; López-Lorenzo, José L.; Gil, Cristina; Vidriales, Maria Belén; Falantes-González, José Francisco CSIC ORCID; Serrano, Alfons; Labrador, Jorge; Sayas, María-José; Foncillas, María-Ángeles; Amador Barciela, María L.; Olave, María-Teresa; Colorado, Mercedes; Gascón, Adriana; Fernández, María Á.; Simiele, Adriana; Pérez-Encinas, Manuel; Rodríguez-Veiga, Rebeca; García, Olga CSIC ORCID; Martínez-López, Joaquín; Barragán, Eva; Paiva, Bruno; Sanz, Miguel Ángel CSIC ORCID; Montesinos, Pau | artículo |
| openAccess |  | ene-2019 | Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval | Rodríguez-Arbolí, Eduardo CSIC ORCID; Márquez-Malaver, Francisco José; Rodríguez-Torres, Nancy; Caballero-Velázquez, Teresa CSIC ORCID; Escamilla-Gómez, Virginia CSIC ORCID; Calderón-Cabrera, Cristina CSIC; Falantes-González, José Francisco CSIC ORCID; Solé Rodriguez, María; García-Ramírez, Patricia; Moya-Arnao, María; Carreras, Enric; Espigado, Ildefonso CSIC ORCID; Pérez-Simón, José A. CSIC ORCID | artículo |
| openAccess |  | 14-dic-2017 | Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens | Seymour, John F.; Döhner, Hartmut; Butrym, Aleksandra; Wierzbowska, Agnieszka; Selleslag, Dominik; Jang, Jun Ho; Kumar, Rajat; Cavenagh, James; Schuh, Andre C.; Candoni, Anna; Récher, Christian; Sandhu, Irwindeep; Bernal del Castillo, Teresa; Al-Ali, Haifa Kathrin; Falantes-González, José Francisco CSIC ORCID; Stone, Richard M.; Minden, Mark D.; Weaver, Jerry; Songer, Steve; Beach, C. L.; Dombret, Hervé | artículo |
| closedAccess |  | mar-2018 | KIT D816V− chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation | Prats-Martín, Concepción; Jiménez-Guerrero, Patricia; Morales-Camacho, Rosario M. CSIC ORCID; Caballero-Velázquez, Teresa CSIC ORCID; Vargas, Mª Teresa; Pérez-López, Olga; Montero, Isabel CSIC ORCID ; Falantes-González, José Francisco CSIC ORCID; Burillo-Sanz, Sergio CSIC ORCID; Carrillo Cruz, Estrella; Borrero, Juan J.; Bernal, Ricardo; Pérez-Simón, José A. CSIC ORCID | artículo |
| closedAccess | | nov-2023 | Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes | Haque, Tamanna; López-Cadenas, Félix; Xicoy, Blanca; Alfonso-Pierola, Ana; Platzbecker, Uwe; Avivi, Irit; Brunner, Andrew M.; Chromik, Jöerg; Morillo, Daniel; Patel, Manish R.; Falantes-González, José Francisco CSIC ORCID; Leitch, Heather A.; Germing, Ulrich; Preis, Meir; Lenox, Laurie; Lauring, Josh; Brown, Regina J.; Kalota, Anna; Mehta, Jaydeep; Pastore, Friederike; Gu, Junchen; Mistry, Pankaj; Valcárcel, David | artículo |
| closedAccess |  | 2018 | Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia | Sanchez-Garcia, Joaquin; Falantes-González, José Francisco CSIC ORCID; Medina Perez, Angeles; Hernandez-Mohedo, Francisca; Hermosín, Lourdes; Torres-Sabariego, Angeles; Bailen, Alicia; Hernandez-Sánchez, Jesus M.; Solé Rodriguez, María; Casaño, Francisco Javier; Calderón-Cabrera, Cristina CSIC; Labrador, Maria; Vahí, Maria; Serrano-López, Josefina; Lumbreras, Eva CSIC ORCID; Hernández, Jesús M. CSIC ORCID | artículo |
| closedAccess |  | dic-2022 | SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome | Falantes-González, José Francisco CSIC ORCID; Márquez-Malaver, Francisco José; Carrillo Cruz, Estrella; García Culebras, Marta; Morales, Rosario; Prats, Concepción; Vargas, Maria T.; Caballero, Teresa; Rodríguez-Arbolí, Eduardo CSIC ORCID; Espigado, Ildefonso CSIC ORCID; Pérez-Simón, José A. CSIC ORCID | artículo |
| openAccess |  | 18-may-2021 | The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial | Ayala, Rosa; Rapado, Inmaculada; Onecha, Esther CSIC ORCID; Martínez-Cuadrón, David; Carreño-Tarragona, Gonzalo; Bergua, Juan; Vives, Susana; Lorenzo Algarra, Jesús; Tormo, Mar; López Martínez, Pilar CSIC ORCID ; Serrano-López, Josefina; Herrera, Pilar; Ramos, Fernando; Salamero, Olga; Lavilla, Esperanza; Gil, Cristina; López Lorenzo, José Luis; Vidriales, Maria Belén; Labrador, Jorge; Falantes-González, José Francisco CSIC ORCID; Sayas, María-José; Paiva, Bruno; Barragán, Eva; Prósper, Felipe; Sanz, Miguel Ángel CSIC ORCID; Martínez-López, Joaquín; Montesinos, Pau | artículo |
